Medtronic Plc
(NYSE : MDT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ISRGIntuitive Surgical, Inc.
-0.32%490.142.4%$512.30m
TMOThermo Fisher Scientific Inc.
-2.02%261.631.0%$443.02m
MDTMedtronic PLC
-0.42%87.740.6%$416.67m
ABTAbbott Laboratories
-0.82%75.970.8%$397.35m
BDXBecton, Dickinson and Company
1.11%228.431.1%$377.30m
ALGNAlign Technology, Inc.
-2.50%322.616.3%$374.21m
BSXBoston Scientific Corporation
-0.82%37.311.1%$323.08m
ABMDABIOMED, Inc.
-0.63%260.483.3%$266.93m
SYKStryker Corporation
-0.81%184.131.3%$242.62m
BAXBaxter International Inc.
-1.20%75.981.7%$206.97m
EWEdwards Lifesciences Corporation
-2.25%173.151.2%$206.76m
WATWaters Corporation
-0.91%208.213.8%$161.98m
ZBHZimmer Biomet Holdings, Inc.
-1.33%116.511.7%$149.84m
DXCMDexCom, Inc.
-1.15%118.048.3%$134.88m
TNDMTandem Diabetes Care, Inc.
-4.00%67.134.0%$128.89m

Company Profile

Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.